Eczacılık Fakültesi

Akademik Kadro

Dr. Öğr. Üyesi Merve  Arıcı

Dr. Öğr. Üyesi
Merve Arıcı

Farmasotik Toksikoloji

Lisans eğitimini Abant İzzet Baysal Üniversitesi, Fen-Edebiyat Fakültesi Biyoloji Bölümü’nde 2013 yılında tamamlayan Merve Arıcı, yüksek lisans eğitimini 2015 yılında İstanbul Üniversitesi, Sağlık Bilimleri Enstitüsü, Farmasötik Toksikoloji Programı’nda tamamlamıştır. Doktora eğitimini de, İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü, Farmasötik Toksikoloji Programı’nda tamamlayan Merve Arıcı, İstinye Üniversitesi'nde öğretim üyesi olarak akademik kadroda bulunmaktadır.

Araştırma Alanları

  • Farmasötik Toksikoloji
  • Farmakogenetik

Çalışma Alanları

  • Sağlık Bilimleri Temel Alanı
  • Farmasotik Toksikoloji
  • Evaluation of lesinurad-induced cardiotoxicity in cardiomyoblastic cells, 2022
  • Does pendimethalin develop in pancreatic cancer induced inflammation?, 2020
  • Association between genetic polymorphism and levothyroxine bioavailability in hypothyroid patients, 2018
  • Investigation of the toxicity of bismuth oxide nanoparticles in various cell lines, 2017
  • Genetic profiles of CYP1A1, CYP1A2 and CYP2E1 enzymes as susceptibility factor in xenobiotic toxicity in Turkish Population, 2016
  • The evaluation of CYP3A4 and CYP3A5 Genetic Profiles in Turkish Population, 2016
  • Investigation on the toxicity of bismuth oxide nanoparticles in different cell lines, 2016
  • Genetic variations in Phosholipase C-epsilon 1 (PLCE1) and susceptibility to colorectal cancer risk: a case-control study in Turkish population, 2016
  • In vitro toxicological assessment of magnesium oxide nanoparticle exposure in several mammalian cell types, 2016
  • CYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population, 2016
  • Suların dezenfeksiyonunda oluşan yan ürünlerin riskleri, 2015
  • The effects of endocrine disrupting chemicals and genetic susceptibility on male infertility, 2015
  • In vitro Evaluation of Oxidative Stress Induction of Triadimenol, 2024
  • Toxicological assessment of magnesium oxide nanoparticle exposure in liver, 2017
  • Investigation on the toxicity of bismuth oxide nanoparticles in HepG2 cell line,
  • Individiual variability in coumarin-induced toxicity,
  • Interaction between the male infertility and the genetic susceptibility to endocrine disruptors, 2014
  • Genomic-based biomarkers of drug-induced nephrotoxicity, 2015
  • Genetic variations in phospholipase C-Epsilon 1 (PLCE1) and susceptibility to colorectal cancer risk: A case-control study in turkish population, 2015
  • Genotyping and haplotyping analysis of drug-metabolizing enzymes CYP1A1, -1A2, -2D6, -2C9, -2C19, -2E1, -3A4 and -3A5 in Turkish population, 2015
  • Drug-induced liver injury (DILI) and genetic susceptibility, 2015
  • Tıbbın Yeni Bir Alanı Fonksiyonel Tıp, ISBN: 978-625-6598-65-2, 2024